FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market.

FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era

The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Digital Journal

Outdated technology makes flu vaccine only 20 percent effective

The ineffectiveness of this year’s current flu vaccine was evident when Australia, whose flu season runs from May through October, resulted in more than two-and-a-half times the number of laboratory ...

Moderna upbeat on new flu shot to help educate public about mRNA

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to start a public conversation about how mRNA technology can offer better ...